Table 1.
Characteristics of 398 patients with MRSA bacteremia
| Characteristics | All patients (n = 398) | Patients with IE (n = 44) | Patients without IE (n = 354) |
|---|---|---|---|
| Age | 58.6 ± 17.1 | 44 ± 12.4 | 59.7 ± 17.3 |
| Male | 238 (59.8 %) | 24 (54.5 %) | 214 (60.5 %) |
| Nursing home resident | 58 (14.6 %) | 2 (4.5 %) | 56 (15.8 %) |
| MRSA bacteremia characteristics | |||
| Community | 105 (26.4 %) | 22 (50 %) | 83 (23.4 %) |
| Health care-associated | 224 (56.3 %) | 18 (40.9 %) | 206 (58.2 %) |
| Hospital-acquired | 69 (17.3 %) | 4 (9.1 %) | 65 (18.4 %) |
| Duration of MRSA bacteremia (median) | 4.47 days | 6.86 days | 4.12 days |
| Presumed source of infection | |||
| Graft infection | 10 (2.5 %) | 1 (2.3 %) | 9 (2.5 %) |
| Short term catheter | 55 (13.8 %) | 0 (0 %) | 55 (15.5 %) |
| Implantable catheter | 33 (8.3 %) | 3 (6.8 %) | 30 (8.5 %) |
| Skin/wound | 132 (33.2 %) | 9 (20.5 %) | 123 (34.7 %) |
| Intra-abdominal | 10 (2.5 %) | 1 (2.3 %) | 9 (2.5 %) |
| Respiratory | 48 (12.1 %) | 9 (20.5 %) | 39 (11 %) |
| Para-spinal abscess | 2 (0.5 %) | 1 (2.3 %) | 1 (0.3 %) |
| Urinary tract | 36 (9 %) | 0 (0 %) | 36 (10.3 %) |
| Other | 72 (18.1 %) | 20 (45.5 %) | 52 (14.7 %) |
| Comorbidities | |||
| Diabetes | 161 (40.5 %) | 13 (29.5 %) | 148 (41.8 %) |
| Hemodialysis | 90 (22.6 %) | 4 (9.1 %) | 86 (24.3 %) |
| HIV | 20 (5 %) | 5 (11.4 %) | 15 (4.2 %) |
| Nursing home resident | 58 (14.6 %) | 2 (4.5 %) | 56 (15.8 %) |